↓ Skip to main content

Dove Medical Press

Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant

Overview of attention for article published in International Journal of Nanomedicine, November 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#3 of 4,142)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
62 news outlets
twitter
9 X users
facebook
3 Facebook pages

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
91 Mendeley
Title
Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant
Published in
International Journal of Nanomedicine, November 2015
DOI 10.2147/ijn.s92704
Pubmed ID
Authors

Orli Binyamin, Liraz Larush, Kati Frid, Guy Keller, Yael Friedman-Levi, Haim Ovadia, Oded Abramsky, Shlomo Magdassi, Ruth Gabizon

Abstract

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system and is associated with demyelination, neurodegeneration, and sensitivity to oxidative stress. In this work, we administered a nanodroplet formulation of pomegranate seed oil (PSO), denominated Nano-PSO, to mice induced for experimental autoimmune encephalomyelitis (EAE), an established model of MS. PSO comprises high levels of punicic acid, a unique polyunsaturated fatty acid considered as one of the strongest natural antioxidants. We show here that while EAE-induced mice treated with natural PSO presented some reduction in disease burden, this beneficial effect increased significantly when EAE mice were treated with Nano-PSO of specific size nanodroplets at much lower concentrations of the oil. Pathological examinations revealed that Nano-PSO administration dramatically reduced demyelination and oxidation of lipids in the brains of the affected animals, which are hallmarks of this severe neurological disease. We propose that novel formulations of natural antioxidants such as Nano-PSO may be considered for the treatment of patients suffering from demyelinating diseases. On the mechanistic side, our results demonstrate that lipid oxidation may be a seminal feature in both demyelination and neurodegeneration.

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 91 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Germany 1 1%
Unknown 89 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 18%
Student > Ph. D. Student 13 14%
Student > Bachelor 10 11%
Researcher 8 9%
Professor > Associate Professor 5 5%
Other 14 15%
Unknown 25 27%
Readers by discipline Count As %
Agricultural and Biological Sciences 14 15%
Medicine and Dentistry 11 12%
Pharmacology, Toxicology and Pharmaceutical Science 9 10%
Biochemistry, Genetics and Molecular Biology 8 9%
Neuroscience 7 8%
Other 13 14%
Unknown 29 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 486. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 January 2020.
All research outputs
#54,834
of 25,576,275 outputs
Outputs from International Journal of Nanomedicine
#3
of 4,142 outputs
Outputs of similar age
#630
of 295,307 outputs
Outputs of similar age from International Journal of Nanomedicine
#2
of 112 outputs
Altmetric has tracked 25,576,275 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,142 research outputs from this source. They receive a mean Attention Score of 4.7. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 295,307 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 112 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.